United States & Illumina

United States: The United States is sending a business delegation to China to address long-standing business priorities, regulatory approvals, and market access for its companies.

Illumina: Illumina seeks to rebuild its business after Beijing lifted an export ban, but remains on China's 'unreliable entity' list due to U.S.-China tensions over biotech security.

United States: The United States' solar manufacturing capacity and clean-energy goals are jeopardized by the new policies, potentially leading to higher power costs and slower grid expansion.

Illumina: Illumina, a joint venture between LONGi and Invenergy, has reduced LONGi's ownership stake but remains uncertain about its future.

United States: The United States, led by Donald Trump, is seeking to strengthen economic ties, extend a trade truce, and secure major business deals with China, particularly in key industries.

Illumina: Illumina's Jacob Thaysen is attending the summit as part of the US business delegation.

United States: The United States, led by Donald Trump, is engaging in high-level diplomatic and trade discussions with China, aiming to address issues like tariffs, artificial intelligence, and market access for its companies.

Illumina: Illumina's CEO, Jacob Thaysen, is part of the delegation, representing the biotechnology and genomics industry's interests in U.S.-China trade.

United States: The United States, represented by Donald Trump, is seeking to sign trade deals, discuss Taiwan's status, and establish a Board of Trade with China.

Illumina: Illumina's CEO, Jacob Thaysen, was invited to join Donald Trump's trip to China, suggesting biotech sector interest.

United States: The United States, represented by Donald Trump, is seeking to improve trade relations with China, address the war with Iran, and maintain its commitment to Taiwan.

Illumina: Illumina's CEO, Jacob_Thaysen, was invited to join Donald Trump on his trip to China.